Bernstein said Novo Nordisk’s (NVO) recently released SOUL study results for Rybelsus in the reduction of major cardiovascular events in diabetic patients were modest and not as robust as ...

The study showed that Rybelsus, the company's oral form of semaglutide, slashed the risk of major cardiovascular events by 14% in type 2 diabetes patients who also face cardiovascular or kidney ...

It’s called Rybelsus. How does oral semaglutide work compared to the injectable version? You may be curious if one form of semaglutide is more effective than the other or if one type causes more ...

Oral semaglutide, sold as Rybelsus, reduced the risk of a group of cardiovascular events by 14% compared with placebo in certain patients with Type 2 diabetes in a late-stage study, Novo said Monday.

Its formidable processor, excellent Pencil utility, and a cohesive Apple ecosystem shape that perception, Samsung is vying to change that with its surefooted Galaxy Tab Ultra series. The newly ...

If you’re familiar with last year’s Galaxy Tab S9 lineup, you won’t find too many surprises in the new Galaxy Tab S10 models. The Galaxy Tab S10 Ultra and Tab S10 Plus feature the same high ...

Rybelsus is an oral form of semaglutide, the active ingredient in the company’s blockbuster Ozempic and Wegovy diabetes and weight-loss drugs, and was tested in the trial on diabetic patients ...

Of which is the Galaxy Tab S9 FE. See at Samsung Samsung already has the new tablet for $100 off but the savings don’t stop there. With the proper trade-in, you can receive up to $300 in Samsung ...

Novo Nordisk plans to seek regulatory approval for Rybelsus label expansion by late 2024 or early 2025. On Monday, Novo Nordisk A/S NVO released the headline results from the SOUL Phase 3 ...